Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

被引：0
|
作者：
Goldsmith, Scott R. [1 ]
Covut, Fahrettin [1 ]
Fiala, Mark A. [2 ]
Bradtke, Elizabeth [1 ]
Gasanli, Ayan [1 ]
Christen, Brandon [1 ]
Pachter, Jonathan A. [3 ]
Xiang, Zhifu [1 ]
Iqbal, Zahid [4 ]
Moore, Nathan [5 ]
Ofoma, Uchenna [4 ]
Parikh, Bijal [6 ]
Dubberke, Erik [7 ]
DiPersio, John F. [8 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Hematol & Oncol, Dept Med, St Louis, MO 63110 USA
[3] Verastem, Needham, MA USA
[4] Washington Univ, Sch Med, Dept Anesthesiol, Div Crit Care, St Louis, MO 63110 USA
[5] Missouri Baptist Med Ctr, St Louis, MO USA
[6] Washington Univ, Sch Med, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med, Div Oncol, Dept Internal Med, St Louis, MO 63110 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11185 / 11186
页数：2
相关论文
共 50 条
  • [41] Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial
    Idorn, Thomas
    Knop, Filip K.
    Jorgensen, Morten B.
    Jensen, Tonny
    Resuli, Marsela
    Hansen, Pernille M.
    Christensen, Karl B.
    Holst, Jens J.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    [J]. DIABETES CARE, 2016, 39 (02) : 206 - 213
  • [42] Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
    De Boeck, Ilke
    Cauwenberghs, Eline
    Spacova, Irina
    Gehrmann, Thies
    Eilers, Tom
    Delanghe, Lize
    Wittouck, Stijn
    Bron, Peter A.
    Henkens, Tim
    Gamgami, Imane
    Simons, Alix
    Claes, Ingmar
    Marien, Joachim
    Arien, Kevin K.
    Bakokimi, Diana
    Loens, Katherine
    Jacobs, Kevin
    Ieven, Margareta
    Bruijning-Verhagen, Patricia
    Delputte, Peter
    Coenen, Samuel
    Verhoeven, Veronique
    Lebeer, Sarah
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [43] Bromhexine for Post-exposure COVID-19 Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Tolouian, Ramin
    Moradi, Omid
    Mulla, Zuber D.
    Ziaie, Shadi
    Haghighi, Mehrdad
    Esmaily, Hadi
    Amini, Hossein
    Hassanpour, Rezvan
    Poorheidar, Elham
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Sali, Shahnaz
    Abolghasemi, Sara
    Tehrani, Shabnam
    Tolouian, Audrey C.
    Zali, Alireza
    Sistanizad, Mohammad
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2022, 15 (08)
  • [44] Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
    Shah, Muhammad Raza
    Fatima, Samreen
    Khan, Sehrosh Naz
    Ullah, Shafi
    Himani, Gulshan
    Wan, Kelvin
    Lin, Timothy
    Lau, Johnson Y. N.
    Liu, Qingquan
    Lam, Dennis S. C.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [45] A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
    Rossignol, Jean-Francois
    Bardin, Matthew C.
    Fulgencio, Jessica
    Mogelnicki, Dena
    Brechot, Christian
    [J]. ECLINICALMEDICINE, 2022, 45
  • [46] An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients
    Tang, J. Y.
    Mackay-Wiggan, J. M.
    Aszterbaum, M.
    Lindgren, J.
    Chang, K.
    Coppola, C.
    Campbell, A.
    Chanana, A.
    Marji, J.
    Bickers, D. R.
    Epstein, E. H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S92 - S92
  • [47] ABATACEPT FOR IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS (ATRIUM): A PHASE 3, INVESTIGATOR-INITIATED, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
    Reynolds, Kerry
    Mooradian, Meghan
    Zlotoff, Daniel
    Ridker, Paul
    Neilan, Tomas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A727 - A727
  • [48] Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
    Asadi, Masoomeh
    Sayar, Sara
    Radmanesh, Esmat
    Naghshi, Sina
    Mousaviasl, Sajedeh
    Jelvay, Saeed
    Ebrahimzadeh, Mona
    Mohammadi, Asma
    Abbasi, Samaneh
    Mobarak, Sara
    Bitaraf, Saeid
    Zardehmehri, Fatemeh
    Cheldavi, Ali
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [49] Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
    Xuedong An
    Bo Peng
    Xiaodong Huang
    Hongmei Jiang
    Zhang’e Xiong
    Hong Zhang
    Fengmei Lian
    Yuanming Ba
    Xiaolin Tong
    [J]. Chinese Medicine, 17
  • [50] Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
    De Niet, Sophie
    Tremege, Mickael
    Coffiner, Monte
    Rousseau, Anne-Francoise
    Calmes, Doriane
    Frix, Anne-Noelle
    Gester, Fanny
    Delvaux, Muriel
    Dive, Anne-Francoise
    Guglielmi, Elora
    Henket, Monique
    Staderoli, Alicia
    Maesen, Didier
    Louis, Renaud
    Guiot, Julien
    Cavalier, Etienne
    [J]. NUTRIENTS, 2022, 14 (15)
12345